$BMA

Macro Bank (BMA) outlines massive Banco Macro dividend, reserves and board pay

Macro Bank Inc. (BMA) has filed a Form 6-K detailing proposals for its upcoming shareholders' meeting on April 8, 2026, including a massive dividend plan and allocation of retained earnings. The bank proposes allocating AR$ 290.4 billion of retained earnings from December 31, 2025, with a significant portion going to legal and optional reserves. A proposed dividend of AR$ 300 billion, equivalent to AR$ 469.1969827049 per share, is contingent on authorization from the Argentine Central Bank.

Original reporting
Published Mar 21, 2026, 3:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 21, 2026, 3:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$BMA
Bullish
high confidence
Mentioned
$BMA · $BMA
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$BMABullishHigh
01

Why it matters

The proposed dividend and reserve allocations reflect confidence in the bank's financial stability, potentially boosting investor sentiment.

02

Market read

The news is highly relevant for investors and traders focusing on Argentine financial stocks, especially Macro Bank.

03

What to watch

Potential macroeconomic instability in Argentina may affect the bank's stock performance despite positive news.

Timing: Immediate; news is recent and pertains to upcoming shareholder meeting on April 8, 2026.

Background

Macro Bank (BMA) is a key player in Argentina's banking sector, with recent filings indicating strong earnings and shareholder return plans.

Company-level read

Ticker impact

$BMABullishHigh confidence
Context

The news pertains directly to Macro Bank (BMA), highlighting significant dividend proposals and reserve allocations, which are likely to influence the stock's performance.

Expected impact

Moderate upward movement in the short to medium term, contingent on regulatory approval.

Evidence & confidence

The announced dividend and reserve allocations suggest robust earnings and a commitment to shareholder value, which typically attract investor interest.

$BMABullishHigh confidence
Context

The news is highly relevant as it directly involves Macro Bank's financial strategies and shareholder distributions.

Expected impact

Potential short-term price increase; long-term effects depend on actual dividend payout and regulatory approval.

Evidence & confidence

Large dividends often signal strong financial performance and can attract dividend-focused investors, supporting price appreciation.

Market effects

The banking sector in Argentina may experience increased investor interest due to Macro Bank's strong financial proposals.

Potential positive sentiment in regional markets with exposure to Argentine banks.

Limited; the news primarily impacts regional market dynamics.

Counterpoint

Regulatory approval delays or geopolitical factors could negate the positive impact of the dividend announcement.

Key entities

  • Macro Bank Inc.

    A major Argentine bank involved in retail and corporate banking.

  • Argentine Central Bank

    The regulatory body whose approval is required for the dividend payout.

Related articles

$BMAMed

Banco Macro Announces Results for the Second Quarter of 2026

Banco Macro reported 2Q26 net income of Ps.206.8 billion, up 39% from the previous quarter and 4% year-over-year. Operating income before expenses was Ps.1.29 trillion, down 2% quarter-over-quarter but up 1% year-over-year. The bank's total financing increased 3% quarter-over-quarter but decreased 5% year-over-year. Banco Macro maintains strong solvency and liquidity ratios, with excess capital of Ps.4.1 trillion and liquid assets covering 74% of deposits.

$BMAHigh

Macro Bank Inc. (BMA): Financial results for Q2 2026

Macro Bank Inc. (BMA) furnished an SEC Form 6-K — earnings release. Yes o No x 2Q26 Earnings Release AUGUST 19TH, 2026 BANCO MACRO 2Q26 EARNINGS RELEASE 2 Index 01 Summary 02 Disclaimer 03 Results 04 Financial Assets 05 Public Sector Assets 06 Funding 07 Liquid Assets 08 Solvency 09 Asset Quality 10 2Q26 Snapshot 11 Relevant and Recent Events 12

$BMAMedAI 8/10

Banco Macro Q1 2026 Earnings Call Transcript - Banco Macro (NYSE:BMA)

Banco Macro reported Q1 2026 net income of 139.8 billion pesos, up 28% quarter-on-quarter and 131% year-on-year, according to the earnings call transcript. Operating income before expenses fell 3% vs. Q4 2025 but rose 15% year-on-year. The bank kept 2026 loan growth guidance at 42% nominal and deposit growth at 34% nominal, assuming 28% inflation. NPL ratio was 5.4% with ~110% coverage; cost of risk guidance is 5.5%–6%.

$BKRMed

Baker Hughes (BKR) Secures Order For 76 Gas Turbines

Baker Hughes (BKR) secured an order for 76 NovaLT™16 gas turbines from Dynamis Power Solutions, valued at 1.3 GW, for hypermobile power projects. The turbines are designed for rapid deployment in data centers and oil and gas operations, aligning with Baker Hughes' focus on distributed power and digital infrastructure. Analysts view this as part of the company's strategy for higher-margin, recurring revenue streams.

$AMGNLowAI 8/10

Evolocumab before PCI for acute MI improves LDL control

Amgen's evolocumab (Repatha) improved LDL control in acute MI patients by 1 year when administered early, but did not impact clinical outcomes vs. standard care, according to the AMUNDSEN trial presented at the European Society of Cardiology Congress and published in JAMA. 82% of patients on evolocumab met LDL targets vs. 40% on standard care alone.